Intravenous or intramuscular anti-HBs immunoglobulin for the prevention of hepatitis B reinfection after orthotopic liver transplantation

Transplantation

Volumn 63, Issue 3, 1997, Pages 478-480

  Burbach, Guido J ^a   Bienzle, Ulrich ^a   Neuhaus, Ruth ^b   Hopf, Uwe ^b   Metzger, Wolfram G ^a   Pratschke, Johann ^b   Neuhaus, Peter ^b  

^a Institute of Tropical Medicine   (Germany)

^b HUMBOLDT UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; HEPATITIS B ANTIBODY; HEPATITIS B(E) ANTIGEN; TACROLIMUS; VIRUS DNA;

ADULT; ANTIBODY TITER; ARTICLE; CLINICAL ARTICLE; DRUG COST; GRAFT REJECTION; HEPATITIS B; HUMAN; IMMUNOPROPHYLAXIS; IMMUNOSUPPRESSIVE TREATMENT; INJECTION PAIN; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LIVER FAILURE; LIVER TRANSPLANTATION; PRIORITY JOURNAL; REINFECTION; SERODIAGNOSIS;

ADULT; FEMALE; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS B SURFACE ANTIGENS; HUMANS; IMMUNOGLOBULIN G; INJECTIONS, INTRAMUSCULAR; INJECTIONS, INTRAVENOUS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; RECURRENCE;

EID: 0031034330     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199702150-00027     Document Type: Article

References (9)

1. Demetris AJ, Jaffe R, Sheahan DG, et al. Recurrent hepatitis B in liver allograft recipients: differentiation between viral hepatitis B and rejection. Am J Pathol 1986; 125: 161.
2. Blumhardt G, Neuhaus P, Bechstein WO, et al. Liver transplantation in HBsAg positive patients. Transplant Proc 1990; 22: 1517.
3. Lauchart W, Müller R, Pichelmayr R. Long-term immunoprophylaxis of hepatitis B reinfection in recipients of human liver allografts. Transplant Proc 1987; 19: 4051.
4. Samuel D, Bismuth A, Serres C, et al. HBV-infection after liver transplantation in HBsAg positive patients: experience with long-term immunoprophylaxis. Transplant Proc 1991; 23: 1492.
5. Müller R, Gubernatis G, Farle M, et al. Liver transplantation in HBs antigen (HBsAg) carriers: prevention of hepatitis B virus (HBV) recurrence by passive immunization. Hepatology 1991; 13: 90.
6. König V, Hopf U, Neuhaus P, et al. Long-term follow-up of hepatitis B virus-infected recipients after orthotopic liver transplantation. Transplantation 1994; 58: 553.
7. Baruch Y, Ben-Porath E, Enat R. Immunoprophylaxis with hepatitis B immunoglobulin after liver transplantation: an economical approach. J Hepatol 1994; 20: 153.
8. Wahl M, Hermodsson S, Kjellman H, et al. Recovery and turnover rate of hepatitis B immunoglobulin in volunteers. Dev Biol Stand 1983; 54: 431.
9. Glöckner WM. Kinetik von immunglobulin G nach intra-venöser oder intramuskulärer applikation. In: Korngruber B, ed. Patient, Infektion, immunglobulin. Heidelberg, Berlin: Springer, 1984: 33.